|
|
|
|
|
by toomuchtodo
2334 days ago
|
|
Insulin is a generic. No one is required to be compensated. Pharma had their chance to be reasonable. That time has passed. Not to say that we shouldn’t appropriate intellectual property when necessary (eminent domain or not respecting a patent, as has happened in India and Canada), it’s just not necessary in this case. That doesn’t make us Venezuela, that makes us pragmatic. |
|
One can't argue that the pharma companies are bringing no value, and then demand their specific product because the generic isn't good enough.
https://www.snopes.com/fact-check/insulin-walmart-vial/